MBMartin Baunach

Martin Baunach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin Baunach has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Native Metabolomics Unveils Suomilide Analogs with Potent Trypsin Inhibitory Activity

    by Amira Naimi, Christoph Ulbricht, Tung Lam Trinh, Stefan Kehraus, Teresa Marina Dreckmann, Uwe Linne, Kornelia Hardes, Raphael Reher, Martin Baunach

    Cyanobacteria are well-known for their ability to produce a diverse array of serine protease inhibitors and thus are a promising source of pharmaceutical lead structures. Here, native metabolomics was employed with trypsin to rapidly screen whole cyanobacterial metabolomes and uncover new potent inhibitors. In combination with subsequent correlative LC-HR-MS/MS-based analysis, this led to the fast discovery of the well-characterized natural product family of suomilides from Nostoc sp. KVJ20 as highly potent trypsin inhibitors. Notably, two of the six putative binders were recognized as potential unknown analogs and thus were chosen for isolation and structural elucidation by means of 1D/2D NMR spectroscopy, Marfey's analysis, and bioinformatic investigations. This resulted in the identification of new suomilides G and H (1/2), which were isolated together with the known congeners suomilide B (3) and D (4). We also demonstrated that all four isolated suomilides inhibit trypsin at low nanomolar to high picomolar concentrations in a competitive bioassay, confirming the exceptional potency of this growing compound family as protease inhibitors.


  • Open Access

    A Bifunctional Protease Cleaves the Leader Peptide in the Biosynthesis of Class I Microviridins

    by Nico Brüssow, Stella Scholz, Antje Stindt, Vincent Wiebach, Tino Damaszek, Roderich D. Süssmuth, Elke Dittmann, Martin Baunach

    Microviridins are a prominent family of highly potent serine protease inhibitors, of which individual variants specifically inhibit different types of proteases of pharmacological interest. These natural products of cyanobacterial origin belong to the ribosomally synthesized and posttranslationally modified peptides and feature an unusual cage‐like architecture, which is composed of characteristic lactone and lactam rings. While the modifying enzymes introducing the posttranslational modifications in the course of microviridin biosynthesis are well investigated, the removal of their N‐terminal leader peptides by designated proteases—a key step during maturation—remains enigmatic. In this study, a bioinformatic approach led to the discovery of NosP, which was confirmed as the first specific protease involved in microviridin biosynthesis. In vitro assays with modified precursor peptide, which was obtained from in vitro pathway reconstruction, revealed that NosP is a bifunctional protease, with both endo‐ and aminopeptidase activities. These results, together with the finding that corresponding homologous leader peptides are widespread in cyanobacteria, may pave the way for the efficient production and bioengineering of class I microviridins in vivo and in vitro.


  • Open Access

    Halogenation-Guided Chemical Screening Uncovers Cyanobacterin Analogues from the Cyanobacterium Tolypothrix sp. PCC9009

    by Franziska Schanbacher, Arthur Guljamow, Valerie I. C. Rebhahn, Peter Schmieder, Heike Enke, Elke Dittmann, Martin Baunach, Timo H. J. Niedermeyer

    Halogenated specialized metabolites show high chemical diversity and exhibit a range of biological activities. A targeted screening of a cyanobacteria extract library for halogenated specialized metabolites using HPLC-HRMS combined with MassQL and Haloseeker indicated that several of the extracts contained halogenated compounds, among them an extract of Tolypothrix sp. PCC9009. This freshwater cyanobacterium has been known since the early 1980s for producing the chlorinated specialized metabolite cyanobacterin, containing a γ-lactone core structure with a hydroxy group that is essential for its herbicidal activity against cyanobacteria and green algae. Mass-spectrometry-based molecular networking was employed to explore the chemical space of natural cyanobacterin analogues. This analysis led to the identification of 15 previously unknown compounds structurally related to cyanobacterin, most of which are related to anhydrocyanobacterin, including a dimer formed by [2 + 2] photocycloaddition. Two further analogues, previously reported following heterologous expression of the cyanobacterin biosynthetic gene cluster in E. coli as the nonchlorinated precyanobacterin I and II, were now isolated from the natural cyanobacterin producer. Cytotoxicity assays of cyanobacterin, anhydrocyanobacterin and one further isolated analogue showed only modest activity of the compounds against HCT116 cells.


  • Open Access

    Mixing and Matching of Hybrid Megasynthases is a Hub for the Evolution of Metabolic Diversity in Cyanobacteria

    by Keishi Ishida, Qi Sun, Jonna Teikari, Christian Hertweck, Elke Dittmann, Masahiro Murakami, Martin Baunach

    Modular megasynthases, such as polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), are molecular assembly lines that biosynthesize many pharmaceutically and ecologically important natural products. Understanding how these compounds evolve could inspire the artificial evolution of compound diversity by metabolic engineering. Over the past two decades, a number of seminal studies have significantly contributed to our understanding of natural product evolution. However, the evolution of NRPS and PKS assembly lines remains poorly understood, especially for NRPS/PKS hybrids. Here, we provide substantial evidence for a remarkable cluster‐mixing event involving three cyanobacterial biosynthetic gene clusters (BGCs), resulting in the emergence of novel peptide‐polyketide hybrids that were named minutumamides. By combining retro‐evolutionary analysis with structure‐guided genome mining, we could discover a potential evolutionary ancestor that links nostopeptolide and minutumamide biosynthesis. In addition, we were able to trace nostopeptolide‐related module and domain blocks in various other biosynthetic pathways, indicating a surprisingly vivid mixing and matching of biosynthesis genes in the evolution of NRPS and cis ‐acyltransferase PKS/NRPS pathways, which was previously regarded as a unique feature of trans ‐acyltransferase ( trans ‐AT) PKS. These remarkable insights into the evolutionary plasticity of NRPS‐PKS assembly lines provide valuable guidance for pathway engineers looking for productive combinations that yield “nonnatural” hybrid natural products.


  • Open Access

    Harnessing the potential: advances in cyanobacterial natural product research and biotechnology

    by Martin Baunach, Arthur Guljamow, María Miguel-Gordo, Elke Dittmann

    In order to exploit the enormous natural product potential of cyanobacteria, suitable techniques must be tailored to the special characteristics of the phototrophic prokaryotes.


  • Open Access

    One‐Pot Chemoenzymatic Synthesis of Microviridin Analogs Containing Functional Tags

    by Stella Scholz, Sofia Kerestetzopoulou, Vincent Wiebach, Romina Schnegotzki, Bianca Schmid, Emmanuel Reyna‐González, Ling Ding, Roderich D. Süssmuth, Elke Dittmann, Martin Baunach

    Microviridins are a prominent family of ribosomally synthesized and posttranslationally modified peptides (RiPPs) featuring characteristic lactone and lactam rings. Their unusual cage‐like architecture renders them highly potent serine protease inhibitors of which individual variants specifically inhibit different types of proteases of pharmacological interest. While posttranslational modifications are key for the stability and bioactivity of RiPPs, additional attractive properties can be introduced by functional tags. To date – although highly desirable – no method has been reported to incorporate functional tags in microviridin scaffolds or the overarching class of graspetides. In this study, a chemoenzymatic in vitro platform is used to introduce functional tags in various microviridin variants yielding biotinylated, dansylated or propargylated congeners. This straightforward approach paves the way for customized protease inhibitors with built‐in functionalities that can help to unravel the still elusive ecological roles and targets of this remarkable class of compounds and to foster applications based on protease inhibition.